Follow-Up in Aphasia Caused by Acute Stroke in a Prospective, Randomized, Clinical, and Experimental Controlled Noninvasive Study With an iPad-Based App (Neolexon ®): Study Protocol of the Lexi Study
Discussion: This trial will determine whether speech therapy with the use of Neolexon® is superior to standard logopedic therapy. Subgroups with the greatest response to Neolexon® will be described. The trial was prospectively registered on the “EU Clinical Trials Register” (NCT04080817)1.
Source: Frontiers in Neurology - Category: Neurology Source Type: research
More News: Aphasia | Brain | Clinical Trials | Computers | Depression | Germany Health | Neurology | Speech Therapy | Speech-Language Pathology | Stroke | Study | Training | Universities & Medical Training